Aditum Bio Management Company, LLCFirm match from fund name (lower confidence)
Aditum Bio Fund 3, L.P.
Open, writing first checksEmerging manager
Open: no first sale reported; age from Form D filed May 2024 (approximate)
- Vintage
- Unknown
- Fund size
- $400M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Aditum Bio Fund 3 invests in translational-stage drug development, using its agile operating model for company formation and trial execution.Inferred from the firm's website
02 · Initial check
$4M to $6.67M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Christian Klee, Manager of the General Partner of the Issuer
- Mark Fishman
- Joe Jimenez
- Joshua Gertsman, Manager of the General Partner of the Issuer
- Praveena Kandula, Managing Director of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Aditum Bio invests in translational-stage drug development using its agile operating model for company formation and trial execution.
FUND III Launched: 2024
https://www.aditumbio.com/portfolio
06 · Sources
Last verified: Oct 28, 2026